Aileron Therapeutics, Inc. (ALRN): Price and Financial Metrics
ALRN Price/Volume Stats
| Current price | $2.76 | 52-week high | $7.42 |
| Prev. close | $2.82 | 52-week low | $1.61 |
| Day low | $2.59 | Volume | 115,000 |
| Day high | $3.11 | Avg. volume | 73,891 |
| 50-day MA | $3.48 | Dividend yield | N/A |
| 200-day MA | $3.75 | Market Cap | 59.80M |
ALRN Stock Price Chart Interactive Chart >
Aileron Therapeutics, Inc. (ALRN) Company Bio
Aileron Therapeutics is a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, which represent the first general solution, or "scaffold" for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The company's lead product candidate ALRN-6924 is being evaluated in multiple clinical trials. The company was founded in 2005 and is based in Cambridge, Massachusetts.
ALRN Price Returns
| 1-mo | -24.80% |
| 3-mo | 18.97% |
| 6-mo | -21.37% |
| 1-year | 48.39% |
| 3-year | -80.42% |
| 5-year | -70.64% |
| YTD | -9.47% |
| 2023 | 28.63% |
| 2022 | -78.95% |
| 2021 | -45.88% |
| 2020 | 81.50% |
| 2019 | -31.79% |
Loading social stream, please wait...